BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4064557)

  • 1. Bile lipid secretion in obese and non-obese individuals with and without gallstones.
    Reuben A; Maton PN; Murphy GM; Dowling RH
    Clin Sci (Lond); 1985 Jul; 69(1):71-9. PubMed ID: 4064557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid.
    Reuben A; Qureshi Y; Murphy GM; Dowling RH
    Eur J Clin Invest; 1986 Apr; 16(2):133-42. PubMed ID: 3089808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients.
    Whiting MJ; Hall JC; Iannos J; Roberts HG; Watts JM
    Int J Obes; 1984; 8(6):681-8. PubMed ID: 6533091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
    Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
    Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity.
    Shaffer EA; Small DM
    J Clin Invest; 1977 May; 59(5):828-40. PubMed ID: 856870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of biliary lipid secretion in non-obese cholesterol gallstone patients with normal, young, male volunteers.
    Leiss O; von Bergmann K
    Klin Wochenschr; 1985 Nov; 63(22):1163-9. PubMed ID: 4079281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects.
    Northfield TC; Hofmann AF
    Gut; 1975 Jan; 16(1):1-11. PubMed ID: 806491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects.
    Northfield TC; LaRusso NF; Hofmann AF; Thistle JL
    Gut; 1975 Jan; 16(1):12-7. PubMed ID: 1140620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of chenodiol on biliary lipids and their association with gallstone dissolution in the National Cooperative Gallstone Study (NCGS).
    Grundy SM; Lan SP; Lachin J
    J Clin Invest; 1984 Apr; 73(4):1156-66. PubMed ID: 6368591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary lipid synthesis and secretion in gallstone patients before and during treatment with chenodeoxycholic acid.
    Key PH; Bonorris GG; Marks JW; Chung A; Schoenfield LJ
    J Lab Clin Med; 1980 Jun; 95(6):816-26. PubMed ID: 7381293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients.
    Nilsell K; Angelin B; Liljeqvist L; Einarsson K
    Gastroenterology; 1985 Aug; 89(2):287-93. PubMed ID: 4007420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of low dose chenodeoxycholic acid feeding on biliary lipid metabolism.
    Adler RD; Bennion LJ; Duane WC; Grundy SM
    Gastroenterology; 1975 Feb; 68(2):326-34. PubMed ID: 1116678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.
    Ahlberg J; Angelin B; Einarsson K
    J Lipid Res; 1981 Mar; 22(3):410-22. PubMed ID: 7240966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of low-dose and intermittent chenodeoxycholic acid therapy of gallstones.
    Marks JW; Bonorris GG; Chung A; Coyne MJ; Okun R; Lachin JM; Schoenfield LJ
    Am J Dig Dis; 1977 Oct; 22(10):856-60. PubMed ID: 920688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones.
    von Bergmann K; Epple-Gutsfeld M; Leiss O
    Gastroenterology; 1984 Jul; 87(1):136-43. PubMed ID: 6724256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment biliary lipid composition in white patients with radiolucent gallstones in the National Cooperative Gallstone Study.
    Hofmann AF; Grundy SM; Lachin JM; Lan SP; Baum RA; Hanson RF; Hersh T; Hightower NC; Marks JW; Mekhjian H; Shaefer RA; Soloway RD; Thistle JL; Thomas FB; Tyor MP
    Gastroenterology; 1982 Oct; 83(4):738-52. PubMed ID: 7106505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of obesity and caloric intake on biliary lipid metabolism in man.
    Bennion LJ; Grundy SM
    J Clin Invest; 1975 Oct; 56(4):996-1011. PubMed ID: 1159099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desaturation of bile and cholesterol gallstone dissolution with chenodeoxycholic acid.
    Hofmann AF
    Am J Clin Nutr; 1977 Jun; 30(6):993-1000. PubMed ID: 326024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of biliary lipids in young Chilean women with cholesterol gallstones.
    Valdivieso V; Palma R; Nervi F; Covarrubias C; Severin C; Antezana C
    Gut; 1979 Nov; 20(11):997-1000. PubMed ID: 527876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.